Published in Natl Med J India on January 05, 2007
Indian Academy of Neurology: The Dasgupta Oration 2009, Neural regeneration with stem cells: Rebooting the brain. Ann Indian Acad Neurol (2009) 0.75
Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol (2008) 4.40
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood (2005) 2.23
Diagnostic accuracy of ultrasound for assessment of hemophilic arthropathy: MRI correlation. AJR Am J Roentgenol (2015) 2.07
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. J Clin Oncol (2010) 1.44
Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation. Pediatr Transplant (2008) 1.43
General transcription factor specified global gene regulation in archaea. Proc Natl Acad Sci U S A (2007) 1.42
Intralesional mesenchymal stromal cell transplant in a rodent model of cortical cryoinjury. Neurol India (2011) 1.40
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis (2003) 1.11
Infections in children undergoing allogeneic bone marrow transplantation in India. Pediatr Transplant (2006) 1.09
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
MGDD: Mycobacterium tuberculosis genome divergence database. BMC Genomics (2008) 1.07
Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo. Hum Gene Ther Methods (2013) 1.06
Metabolism of 4-chloro-2-nitrophenol in a gram-positive bacterium, Exiguobacterium sp. PMA. Microb Cell Fact (2012) 1.04
Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biol Blood Marrow Transplant (2009) 1.03
Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country. Cytometry B Clin Cytom (2012) 1.02
Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int (2012) 0.99
Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97
Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer (2008) 0.97
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide. Mediterr J Hematol Infect Dis (2011) 0.95
Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen. Haematologica (2007) 0.95
Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol (2013) 0.95
A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2007) 0.94
Management of hemophilia in patients with inhibitors: the perspective from developing countries. Semin Thromb Hemost (2010) 0.93
Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Eur J Haematol (2005) 0.92
Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene (2006) 0.92
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Blood (2012) 0.91
Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. Am J Hematol (2002) 0.90
Advancing stem cell biology toward stem cell therapeutics. Cell Stem Cell (2012) 0.90
Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia. Pharmacogenomics (2012) 0.89
Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD. Biol Blood Marrow Transplant (2008) 0.89
Promotion of growth in mungbean (Phaseolus aureus Roxb.) by selenium is associated with stimulation of carbohydrate metabolism. Biol Trace Elem Res (2010) 0.88
Proteomic and genomic modulations induced by γ-irradiation of human blood lymphocytes. Int J Radiat Biol (2010) 0.88
Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo. Hum Gene Ther Methods (2013) 0.87
Imatinib-induced erythroderma. Australas J Dermatol (2007) 0.87
Clinical manifestations of combined factor V and VIII deficiency: a series of 37 cases from a single center in India. Am J Hematol (2010) 0.86
Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J Endocrinol (2007) 0.86
The phenotypic heterogeneity of severe hemophilia. Semin Thromb Hemost (2008) 0.86
Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective? Int Urol Nephrol (2011) 0.86
Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients. Haematologica (2007) 0.85
The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases. Cancer Genet Cytogenet (2010) 0.85
Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant. Biol Blood Marrow Transplant (2009) 0.85
Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost (2012) 0.84
Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India. Transplantation (2002) 0.84
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy. Sci Rep (2013) 0.84
Molecular characterization of factor IX gene mutations in 53 patients with haemophilia B in India. Thromb Haemost (2005) 0.83
Mast cell sarcoma of the small intestine: a case report. J Clin Pathol (2011) 0.82
Interaction of hemoglobin E with other abnormal hemoglobins. Acta Haematol (2011) 0.82
Novel degradation pathway of 4-chloro-2-aminophenol via 4-chlorocatechol in Burkholderia sp. RKJ 800. Environ Sci Pollut Res Int (2013) 0.82
A novel splice site mutation c.2278 (-1) G>C in the TMPRSS6 gene causes deletion of the substrate binding site of the serine protease resulting in refractory iron deficiency anaemia. Br J Haematol (2009) 0.82
Identification of rare and novel deletions that cause (δβ)0-thalassaemia and hereditary persistence of foetal haemoglobin in Indian population. Eur J Haematol (2014) 0.82
Rapid detection of beta-globin gene mutations and polymorphisms by temporal temperature gradient gel electrophoresis. Clin Chem (2003) 0.82
A stepwise α-thalassemia screening strategy in high-prevalence areas. Eur J Haematol (2013) 0.82
Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia. Eur J Clin Pharmacol (2012) 0.81
Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3). Hum Mutat (2006) 0.81
Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine. Med Oncol (2009) 0.81
International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India. Acta Haematol (2012) 0.81
Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model. Stem Cells Transl Med (2013) 0.80
External quality assessment scheme for hemostasis in India. Semin Thromb Hemost (2007) 0.80
Surgery for hemophilia in developing countries. Semin Thromb Hemost (2005) 0.80
Gradient nanofiber scaffolds for tissue engineering. J Nanosci Nanotechnol (2013) 0.80
The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers. Clin Transplant (2013) 0.80
Exogenous proline application reduces phytotoxic effects of selenium by minimising oxidative stress and improves growth in bean (Phaseolus vulgaris L.) seedlings. Biol Trace Elem Res (2010) 0.79
Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.79
Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis. Leuk Lymphoma (2011) 0.79
Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism. Hemoglobin (2005) 0.79
Comparative evaluation of two two-dimensional gel electrophoresis image analysis software applications using synovial fluids from patients with joint disease. J Orthop Sci (2005) 0.79
Numerical model for DNA loading in microdevices: stacking and autogating effects. Electrophoresis (2006) 0.78
Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Pediatr Transplant (2007) 0.78
Activation of the cellular unfolded protein response by recombinant adeno-associated virus vectors. PLoS One (2013) 0.78
Size distribution and source apportionment of polycyclic aromatic hydrocarbons (PAHs) in aerosol particle samples from the atmospheric environment of Delhi, India. Sci Total Environ (2011) 0.78
Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions. Leuk Lymphoma (2009) 0.78
EDTA and citric acid mediated phytoextraction of Zn, Cu, Pb and Cd through marigold (Tagetes erecta). J Environ Biol (2010) 0.77
Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost (2006) 0.77
Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant. Biol Blood Marrow Transplant (2010) 0.77
Analysis of oligomeric proteins during unfolding by pH and temperature. J Mol Model (2009) 0.77
Novel NPM1 mutation in the 3'-untranslated region identified in two patients with acute myeloid leukemia. Leuk Lymphoma (2013) 0.76
Endothelial cells do not express GSTA1: potential relevance to busulfan-mediated endothelial damage during haematopoietic stem cell transplantation. Eur J Haematol (2008) 0.76
Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections. Clin Transplant (2009) 0.76
Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India. World J Pediatr (2011) 0.76
Successful surgical hemostasis in patients with von Willebrand disease following infusion of KoateDVI. Thromb Haemost (2002) 0.76
Association of genetic variants with response to iron supplements in pregnancy. Genes Nutr (2015) 0.76
Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. Pediatr Hematol Oncol (2010) 0.76
Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines? Indian J Urol (2012) 0.76
ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia. Ann Hematol (2013) 0.76
Blastic plasmacytoid dendritic cell neoplasm presenting as fever with diffuse cutaneous nodules. Indian J Dermatol (2012) 0.75
A rapid & sensitive liquid chromatography- tandem mass spectrometry method for the quantitation of busulfan levels in plasma & application for routine therapeutic monitoring in haematopoietic stem cell transplantation. Indian J Med Res (2013) 0.75
Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India. Leuk Lymphoma (2011) 0.75
A novel deletion of β-globin promoter causing high HbA2 in an Indian population. Haematologica (2012) 0.75
T/NK-cell post-transplant lymphoproliferative disorder of the urinary bladder: a case report. J Clin Pathol (2010) 0.75
Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterization and structural implications. Br J Haematol (2013) 0.75
Hb Lepore in the Indian population. Hemoglobin (2003) 0.75
Intragenic codon bias in a set of mouse and human genes. J Theor Biol (2004) 0.75
Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review. Blood Coagul Fibrinolysis (2017) 0.75
Molecular remission with arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia. Haematologica (2004) 0.75
Immunosuppressive Therapy and Bone Marrow Transplantation for Aplastic Anaemia--The CMC Experience. J Assoc Physicians India (2015) 0.75
Coexistence of a novel beta-globin gene deletion (codons 81-87) with the codon 30 (G-->C) mutation in an Indian patient with beta0-thalassemia. Hemoglobin (2002) 0.75
Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen. Biol Blood Marrow Transplant (2017) 0.75